...
首页> 外文期刊>Immunity >Interleukin-13 Activates Distinct Cellular Pathways Leading to Ductular Reaction, Steatosis, and Fibrosis
【24h】

Interleukin-13 Activates Distinct Cellular Pathways Leading to Ductular Reaction, Steatosis, and Fibrosis

机译:白介素13激活不同的细胞途径,导致导管反应,脂肪变性和纤维化

获取原文
获取原文并翻译 | 示例
           

摘要

Fibroproliferative diseases are driven by dysregulated tissue repair responses and are a major cause of morbidity and mortality because they affect nearly every organ system. Type 2 cytokine responses are critically involved in tissue repair; however, the mechanisms that regulate beneficial regeneration versus pathological fibrosis are not well understood. Here, we have shown that the type 2 effector cytokine interleukin-13 simultaneously, yet independently, directed hepatic fibrosis and the compensatory proliferation of hepatocytes and biliary cells in progressive models of liver disease induced by interleukin-13 overexpression or after infection with Schistosoma mansoni. Using transgenic mice with interleukin-13 signaling genetically disrupted in hepatocytes, cholangiocytes, or resident tissue fibroblasts, we have revealed direct and distinct roles for interleukin-13 in fibrosis, steatosis, cholestasis, and ductular reaction. Together, these studies show that these mechanisms are simultaneously controlled but distinctly regulated by interleukin-13 signaling. Thus, it may be possible to promote interleukin-13-dependent hepatobiliary expansion without generating pathological fibrosis.
机译:纤维增生性疾病是由组织修复反应失调驱动的,是发病率和死亡率的主要原因,因为它们几乎影响每个器官系统。 2型细胞因子反应与组织修复至关重要。然而,调节有益再生与病理性纤维化的机制尚不十分清楚。在这里,我们已经显示,在由白细胞介素13过度表达或曼氏血吸虫感染诱发的肝病进行性模型中,2型效应细胞因子白细胞介素13同时但独立地指导肝纤维化以及肝细胞和胆道细胞的代偿性增生。使用具有在肝细胞,胆管细胞或常驻组织成纤维细胞中基因突变的白介素13信号转基因的小鼠,我们已经揭示了白介素13在纤维化,脂肪变性,胆汁淤积和导管反应中的直接作用。总之,这些研究表明,这些机制同时受白介素13信号控制,但受到明显调节。因此,有可能促进白介素13依赖性肝胆扩张而不产生病理性纤维化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号